Discovery to Impact at The University of Texas at Austin has invested $250,000 in ClearCam Inc., a UTaffiliated startup that has launched a technology cleared by the Food and Drug Administration that drastically improves visualization and safety in laparoscopic procedures. This is the second investment made by UT Austin’s $10 million Seed Fund.
ClearCam’s ClearScope, a disposable in-vivo laparoscopic lens cleaner, eliminates the need for clinicians to continually remove and clean a scope during surgery. It enables surgeons to maintain their visual field and momentum throughout surgery, reduces a patient’s time in the OR, and maximizes surgical excellence while improving surgical safety. The device has been used in more than 1,600 procedures across the country and is gaining traction in thoracic, general, and gynecologic surgeries.
ClearCam was born in 2018 out of a collaboration between Dell Medical School, the Cockrell School of Engineering, the Texas Innovation Center, and the Austin Technology Incubator.
